Salicylamide-induced anaphylaxis: increased urinary leukotriene E4 and prostaglandin D2 metabolite.
Ono
E
E
Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara Hospital, Sakuradai 18-1, Sagamihara, Kanagawa 228-8522, Japan. e-ono@sagamihara-hosp.gr.jp
Taniguchi
M
M
Mita
H
H
Akiyama
K
K
D000293:Adolescent; D000707:Anaphylaxis / Q000139:chemically induced* / Q000652:urine; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D015237:Dinoprost / Q000652:urine*; D004342:Drug Hypersensitivity / Q000209:etiology* / Q000652:urine; D005260:Female; D006801:Humans; D017999:Leukotriene E4 / Q000652:urine*; D015230:Prostaglandin D2 / Q000378:metabolism; D012457:Salicylamides / Q000009:adverse effects*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D012457:Salicylamides; D017999:Leukotriene E4; D015237:Dinoprost; C031060:salicylamide; D015230:Prostaglandin D2